Thank you, Bruce. On September 30, 2023, our net asset value per share stood at $4.81, compared to a net asset value per share of $4.34 as of June 30. For the quarter ended September, we recorded GAAP total investment income of approximately $74.4 million, representing an increase of approximately $3.9 million from the prior quarter. The quarter's GAAP total investment income from our portfolio consisted of approximately $69.3 million from our CLO equity and CLO warehouse investments and approximately $5.1 million from our CLO debt investments and from other income. Oxford Lane recorded GAAP net investment income of approximately $44.8 million or $0.23 per share for the quarter ended September, compared to approximately $42 million or $0.24 per share for the quarter ended June 30. Our core net investment income was approximately $79.7 million or $0.41 per share for the quarter ended September, compared with approximately $75 million or $0.43 per share for the quarter ended June 30. Quarter ended September, we recorded net realized losses of approximately $10.5 million and net unrealized appreciation on investment of approximately $95.8 million or $0.44 per share in total. We had a net increase in net assets resulting from operations of approximately $130.1 million or $0.67 per share for the second fiscal quarter. As of September 30, the following metrics applied. We note that none of these metrics represented a total return to shareholders. The weighted average yield of our CLO debt investments at current cost was 18.5% up from 18.1% as of June 30. The weighted average effective yield of our CLO equity investments at current cost was 16.3%, up from 16% as of June 30. The weighted average cash distribution yield of our CLO equity investments at current cost was 25%, up from 24.6% as of June 30. We note that the cash distribution yields calculated on our CLO equity investments are based on the cash distributions we've received or which we were entitled to receive at each respective period end. During the quarter ended September, we issued a total of approximately 20.8 million shares of our common stock pursuant to an at-the-market offering, resulting in net proceeds of approximately $104.8 million, which resulted in net accretion to shareholders of approximately $0.07 per share of NAV for the quarter. During the quarter ended September, we made additional CLO investments of approximately $171.7 million and we received approximately $11.8 million from sales and from repayments. On October 26, our Board of Directors declared monthly common stock distributions of $0.08 per share for each of the months ending January, February and March of 2024. With that, I'll turn the call over to our Managing Director, Joe Kupka.